Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?

Norrby S R

Department of Infectious Diseases, University of Lund, Lund University Hospital, Sweden.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:99-101. doi: 10.1093/jac/40.suppl_1.99.

Abstract

摘要

相似文献

J Antimicrob Chemother. 1997 Dec;40 Suppl A:99-101. doi: 10.1093/jac/40.suppl_1.99.

Pneumologie. 1997 Sep;51(9 Suppl):1-4.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:27-30. doi: 10.1093/jac/40.suppl_1.27.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:1-4. doi: 10.1093/jac/40.suppl_1.1.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:19-25. doi: 10.1093/jac/40.suppl_1.19.

Drugs. 1995;49 Suppl 2:253-5. doi: 10.2165/00003495-199500492-00059.

Med Lett Drugs Ther. 1998 Jan 30;40(1019):17-8.

Jpn J Antibiot. 1994 Oct;47(10):1241-58.

Clin Ther. 1999 Jan;21(1):172-88. doi: 10.1016/S0149-2918(00)88277-6.

J Antimicrob Chemother. 1997 Dec;40 Suppl A:45-57. doi: 10.1093/jac/40.suppl_1.45.

Antimicrob Agents Chemother. 2001 Jun;45(6):1654-9. doi: 10.1128/AAC.45.6.1654-1659.2001.

Thorax. 2000 Jan;55(1):83-5. doi: 10.1136/thorax.55.1.83.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。